Benjamin Li
Aug 30, 2010

Grey Korea wins Daewon Pharmaceutical's AOR account

SEOUL - After a six-way competitive pitch, Daewon Pharmaceutical Company has chosen Grey Korea as its agency-of-record. The initial contract is for one year.

Grey Korea wins Daewon Pharmaceutical's AOR account

The mandate includes creative duties for advertising, public relations, online marketing, promotions and event management.

“Daewon Pharmaceutical Company is a leading firm in its field and we are proud to be associated with a Korean-based company with a solid reputation. We look forward to forming a strong partnership with their team as we work with them to further elevate their brand locally and beyond,” says TK Kwon, group account director, Grey Korea.
 
The Daewon Pharmaceutical Company appointment follows recent successes, with Grey Korea picking up Allergan’s Botox, Juvederm, Natrelle and Latisse brands, as well as its activation marketing arm G2 Korea launching Subway’s first ever campaign in the country.

Grey Korea also counts the Boerhringer Ingelheim account as part of its health care client portfolio.


Source:
Campaign Asia

Related Articles

Just Published

20 hours ago

IPG unites agencies and clients under all-in-one ...

The move forms part of a larger trend for holding companies to break down information silos across their agencies and partners with shared platforms.

20 hours ago

Superloop wants to set Aussies free from slow internet

The campaign urges Australians to stand up to their expensive internet providers by bringing back an iconic meme from the early 2010’s: planking.

20 hours ago

Move and win roundup: Week of October, 21

Your Monday marcomms news starts here: leadership shakeup at JCDecaux ANZ, McDonald's, Australia's third largest advertiser launches a creative review, plus Clemenger's talent grab, and luxury brand wins for We Red Bridge communications.

21 hours ago

GroupM wins Honor’s global media account, taking ...

EXCLUSIVE: The contract will run from 2025 to 2028, with an option for a one-year extension.